← Browse by Condition
Medical Condition

biliary tract cancers

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06564623 Phase 1
Recruiting

Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)

Enrollment
25 pts
Location
United States
Sponsor
Sidney Kimmel Comprehensive Ca...
View Trial →